Literature DB >> 20124180

Temporal trends in cause-specific late mortality among 5-year survivors of childhood cancer.

Gregory T Armstrong1, Zhenyu Pan, Kirsten K Ness, Deokumar Srivastava, Leslie L Robison.   

Abstract

PURPOSE: Five-year survival rates for childhood cancer have improved over the past four decades. However, it is unknown whether changes in primary cancer therapy have improved rates of long-term (> 5 years from diagnosis) durable remissions and reduced treatment-related deaths. We investigated changes in patterns of late mortality over time and cause-specific attribution of late-mortality among 5-year survivors. PATIENTS AND METHODS: Using data from the Surveillance, Epidemiology and End Results (SEER) population-based registry, we assessed all-cause and cause-specific (recurrence/progression of primary disease, external cause, and nonrecurrence/nonexternal cause) late mortality during four consecutive time periods from 1974 through 2000 among 26,643 5-year survivors of childhood cancer.
RESULTS: All-cause late mortality improved during more recent eras, dropping from 7.1% (95% CI, 6.4% to 7.8%) among children diagnosed during 1974 to 1980 to 3.9% (95% CI, 3.3% to 4.4%) among children diagnosed during 1995 to 2000 (P < .001), largely because of reduced mortality from recurrence or progression. While there was no significant reduction in mortality attributable to other health conditions (including treatment-related health conditions), analysis controlling for demographic characteristics identified a trend toward reduced risk during more recent eras (P = .007). Disparity by race/ethnicity was identified, with higher mortality among non-Hispanic blacks than among non-Hispanic whites for all-cause and nonrecurrence/nonexternal -cause late mortality.
CONCLUSION: While overall patterns of mortality from other health conditions do not differ over time, adjustment for demographic characteristics provides evidence that risk of treatment-related mortality may be lower in more recent eras. Disparities in health care utilization among survivors should be explored.

Entities:  

Mesh:

Year:  2010        PMID: 20124180      PMCID: PMC3102544          DOI: 10.1200/JCO.2009.24.4608

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  30 in total

1.  Differences in outcome in adolescents with acute lymphoblastic leukemia: a consequence of better regimens? Better doctors? Both?

Authors:  Charles A Schiffer
Journal:  J Clin Oncol       Date:  2003-03-01       Impact factor: 44.544

2.  Decreasing late mortality among five-year survivors of cancer in childhood and adolescence: a population-based study in the Nordic countries.

Authors:  T R Möller; S Garwicz; L Barlow; J F Winther; E Glattre; G Olafsdottir; J H Olsen; R Perfekt; A Ritvanen; R Sankila; H Tulinius
Journal:  J Clin Oncol       Date:  2001-07-01       Impact factor: 44.544

3.  The course of five-year survivors of cancer in childhood.

Authors:  F P Li; M H Myers; H W Heise; N Jaffe
Journal:  J Pediatr       Date:  1978-08       Impact factor: 4.406

4.  Glutathione S-transferase polymorphisms and outcome of chemotherapy in childhood acute myeloid leukemia.

Authors:  S M Davies; L L Robison; J D Buckley; T Tjoa; W G Woods; G A Radloff; J A Ross; J P Perentesis
Journal:  J Clin Oncol       Date:  2001-03-01       Impact factor: 44.544

5.  A comparative study of central nervous system irradiation and intensive chemotherapy early in remission of childhood acute lymphocytic leukemia.

Authors:  R J Aur; J V Simone; H O Hustu; M S Verzosa
Journal:  Cancer       Date:  1972-02       Impact factor: 6.860

6.  Results of therapy for acute lymphoblastic leukemia in black and white children.

Authors:  Ching-Hon Pui; John T Sandlund; Deqing Pei; Gaston K Rivera; Scott C Howard; Raul C Ribeiro; Jeffrey E Rubnitz; Bassem I Razzouk; Melissa M Hudson; Cheng Cheng; Susana C Raimondi; Frederick G Behm; James R Downing; Mary V Relling; William E Evans
Journal:  JAMA       Date:  2003-10-15       Impact factor: 56.272

7.  Extended follow-up of long-term survivors of childhood acute lymphoblastic leukemia.

Authors:  Ching-Hon Pui; Cheng Cheng; Wing Leung; Shesh N Rai; Gaston K Rivera; John T Sandlund; Raul C Ribeiro; Mary V Relling; Larry E Kun; William E Evans; Melissa M Hudson
Journal:  N Engl J Med       Date:  2003-08-14       Impact factor: 91.245

Review 8.  Influence of race and socioeconomic status on outcome of children treated for childhood acute lymphoblastic leukemia.

Authors:  Smita Bhatia
Journal:  Curr Opin Pediatr       Date:  2004-02       Impact factor: 2.856

9.  Late mortality experience in five-year survivors of childhood and adolescent cancer: the Childhood Cancer Survivor Study.

Authors:  A C Mertens; Y Yasui; J P Neglia; J D Potter; M E Nesbit; K Ruccione; W A Smithson; L L Robison
Journal:  J Clin Oncol       Date:  2001-07-01       Impact factor: 50.717

10.  Study design and cohort characteristics of the Childhood Cancer Survivor Study: a multi-institutional collaborative project.

Authors:  Leslie L Robison; Ann C Mertens; John D Boice; Norman E Breslow; Sarah S Donaldson; Daniel M Green; Frederic P Li; Anna T Meadows; John J Mulvihill; Joseph P Neglia; Mark E Nesbit; Roger J Packer; John D Potter; Charles A Sklar; Malcolm A Smith; Marilyn Stovall; Louise C Strong; Yutaka Yasui; Lonnie K Zeltzer
Journal:  Med Pediatr Oncol       Date:  2002-04
View more
  29 in total

1.  Obesity and Metabolic Disease After Childhood Cancer.

Authors:  Dana Barnea; Nirupa Raghunathan; Danielle Novetsky Friedman; Emily S Tonorezos
Journal:  Oncology (Williston Park)       Date:  2015-11       Impact factor: 2.990

2.  Comparative Toxicity by Sex Among Children Treated for Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group.

Authors:  Kathleen A Meeske; Lingyun Ji; David R Freyer; Paul Gaynon; Kathleen Ruccione; Anna Butturini; Vassilios I Avramis; Stuart Siegel; Yousif Matloub; Nita L Seibel; Richard Sposto
Journal:  Pediatr Blood Cancer       Date:  2015-07-14       Impact factor: 3.167

3.  Cost-effectiveness of the children's oncology group long-term follow-up screening guidelines for childhood cancer survivors at risk for treatment-related heart failure.

Authors:  F Lennie Wong; Smita Bhatia; Wendy Landier; Liton Francisco; Wendy Leisenring; Melissa M Hudson; Gregory T Armstrong; Ann Mertens; Marilyn Stovall; Leslie L Robison; Gary H Lyman; Steven E Lipshultz; Saro H Armenian
Journal:  Ann Intern Med       Date:  2014-05-20       Impact factor: 25.391

Review 4.  Opportunities and challenges in the immunological therapy of pediatric malignancy: a concise snapshot.

Authors:  Francesco Ceppi; Maja Beck-Popovic; Jean-Pierre Bourquin; Raffaele Renella
Journal:  Eur J Pediatr       Date:  2017-08-12       Impact factor: 3.183

5.  Racial Differences in 20-Year Cardiovascular Mortality Risk Among Childhood and Young Adult Cancer Survivors.

Authors:  Amy M Berkman; Abenaa M Brewster; Lee W Jones; Jun Yu; J Jack Lee; S Andrew Peng; Abigail Crocker; Joann L Ater; Susan C Gilchrist
Journal:  J Adolesc Young Adult Oncol       Date:  2017-05-22       Impact factor: 2.223

Review 6.  Long-term effects of radiation exposure among adult survivors of childhood cancer: results from the childhood cancer survivor study.

Authors:  Gregory T Armstrong; Marilyn Stovall; Leslie L Robison
Journal:  Radiat Res       Date:  2010-09-17       Impact factor: 2.841

7.  Noncancer-related mortality risks in adult survivors of pediatric malignancies: the childhood cancer survivor study.

Authors:  Cheryl L Cox; Vikki G Nolan; Wendy Leisenring; Yutaka Yasui; Susan W Ogg; Ann C Mertens; Joseph P Neglia; Kirsten K Ness; Gregory T Armstrong; Les L Robison
Journal:  J Cancer Surviv       Date:  2014-04-10       Impact factor: 4.442

8.  Late causes of death in children treated for CNS malignancies.

Authors:  Stephanie M Perkins; Wan Fei; Nandita Mitra; Eric T Shinohara
Journal:  J Neurooncol       Date:  2013-07-05       Impact factor: 4.130

Review 9.  Minimal Residual Disease Evaluation in Childhood Acute Lymphoblastic Leukemia: An Economic Analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2016-03-08

10.  Survival and cure trends for European children, adolescents and young adults diagnosed with acute lymphoblastic leukemia from 1982 to 2002.

Authors:  Gemma Gatta; Silvia Rossi; Roberto Foschi; Annalisa Trama; Rafael Marcos-Gragera; Guido Pastore; Rafael Peris-Bonet; Charles Stiller; Riccardo Capocaccia
Journal:  Haematologica       Date:  2013-02-12       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.